CD47 and neoplasm: In addition, CD47 knockdown using shRNA in the SK-OV-3 ovarian cancer cell line promoted in vitro macrophage phagocytosis and inhibited tumor initiation in vivo, suggesting that such an anti-tumor effect is CD47 dependent.